Firefly Neuroscience (NASDAQ:AIFF) Stock Price Up 0.6% – Here’s What Happened

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shot up 0.6% on Tuesday . The company traded as high as $1.6820 and last traded at $1.61. 185,285 shares changed hands during trading, a decline of 50% from the average session volume of 373,226 shares. The stock had previously closed at $1.60.

Analyst Upgrades and Downgrades

AIFF has been the subject of a number of recent research reports. Wall Street Zen upgraded Firefly Neuroscience from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Weiss Ratings raised shares of Firefly Neuroscience from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Firefly Neuroscience Trading Up 0.6%

The business’s fifty day simple moving average is $1.85 and its 200-day simple moving average is $1.48. The firm has a market cap of $25.07 million, a P/E ratio of -2.56 and a beta of 0.52.

Firefly Neuroscience (NASDAQ:AIFF) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.13) EPS for the quarter. The firm had revenue of $0.49 million for the quarter. Firefly Neuroscience had a negative net margin of 565.40% and a negative return on equity of 94.68%.

Institutional Trading of Firefly Neuroscience

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in Firefly Neuroscience by 393.3% in the third quarter. Vanguard Group Inc. now owns 503,071 shares of the company’s stock valued at $1,464,000 after acquiring an additional 401,085 shares in the last quarter. Geode Capital Management LLC raised its holdings in Firefly Neuroscience by 92.9% in the 2nd quarter. Geode Capital Management LLC now owns 120,604 shares of the company’s stock worth $341,000 after purchasing an additional 58,067 shares in the last quarter. Jane Street Group LLC bought a new position in Firefly Neuroscience in the 4th quarter worth $53,000. Finally, Savvy Advisors Inc. purchased a new position in shares of Firefly Neuroscience during the third quarter valued at about $63,000. Hedge funds and other institutional investors own 4.96% of the company’s stock.

About Firefly Neuroscience

Firefly Neuroscience is a clinical‐stage neurotechnology company focused on developing digital biomarkers and cognitive assessment tools for the early detection and monitoring of neurological disorders. The company’s platform combines mobile applications, sensor technology and advanced analytics to capture objective brain function data outside of traditional clinical settings. By providing real‐world cognitive and physiological measurements, Firefly aims to improve diagnosis, track disease progression and support therapeutic development.

The company’s flagship offering is a smartphone‐based cognitive assessment app that guides users through a series of interactive tasks designed to measure attention, memory, processing speed and executive function.